Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Mann

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Gut|October 1, 1992
Ultrarapid urease testH J Mann
Critical Care Clinics|November 9, 2000
Pharmacy technology of the ICU. Today and tomorrowH J Mann
Clinical Pharmacy|November 1, 1990
Moricizine: a new class I antiarrhythmicH J Mann
Drug Intelligence & Clinical Pharmacy|November 1, 1986
Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patientsH J Mann, H Buchwald
American Journal of Hospital Pharmacy|June 1, 1986
Cost analysis of substituting labetalol for nitroprussideH J Mann, R J Klecker
Pharmacoeconomics|September 5, 1993
Identifying drug usage patterns in the intensive care unitH J Mann, E T Wittbrodt
Drug Intelligence & Clinical Pharmacy|July 1, 1984
Intrinsic sympathomimetic activity: physiological reality or marketing phenomenonC D Black, H J Mann
Critical Care Nursing Clinics of North America|June 1, 1993
Immunotherapy targets in critical careH J Mann, K Vance-Bryan
Archiv Fur Klinische Und Experimentelle Ohren- Nasen- Und Kehlkopfheilkunde|January 1, 1971
[Studies on the influence of vitamin A on the immune response]H J Mann, T Diamantstein, B Wagner
Journal of Veterinary Pharmacology and Therapeutics|November 7, 2006
Pharmacokinetics of tiletamine and zolazepam (Telazol) in anesthetized pigsA Kumar, H J Mann, R P Remmel
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Gut|October 1, 1992
Ultrarapid urease testH J Mann
Critical Care Clinics|November 9, 2000
Pharmacy technology of the ICU. Today and tomorrowH J Mann
Clinical Pharmacy|November 1, 1990
Moricizine: a new class I antiarrhythmicH J Mann
Drug Intelligence & Clinical Pharmacy|November 1, 1986
Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patientsH J Mann, H Buchwald
American Journal of Hospital Pharmacy|June 1, 1986
Cost analysis of substituting labetalol for nitroprussideH J Mann, R J Klecker
Pharmacoeconomics|September 5, 1993
Identifying drug usage patterns in the intensive care unitH J Mann, E T Wittbrodt
Drug Intelligence & Clinical Pharmacy|July 1, 1984
Intrinsic sympathomimetic activity: physiological reality or marketing phenomenonC D Black, H J Mann
Critical Care Nursing Clinics of North America|June 1, 1993
Immunotherapy targets in critical careH J Mann, K Vance-Bryan
Archiv Fur Klinische Und Experimentelle Ohren- Nasen- Und Kehlkopfheilkunde|January 1, 1971
[Studies on the influence of vitamin A on the immune response]H J Mann, T Diamantstein, B Wagner
Journal of Veterinary Pharmacology and Therapeutics|November 7, 2006
Pharmacokinetics of tiletamine and zolazepam (Telazol) in anesthetized pigsA Kumar, H J Mann, R P Remmel
Pageof 4